throbber
Trials@uspto.gov
`571.272.7822
`
`
`Paper No. 53
`Entered: March 16, 2022
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`LIQUIDIA TECHNOLOGIES, INC.,
`Petitioner,
`
`v.
`
`UNITED THERAPEUTICS CORPORATION,
`Patent Owner.
`____________
`
`IPR2021-00406
`Patent 10,716,793 B2
`____________
`
`
`
`Before ERICA A. FRANKLIN, CHRISTOPHER M. KAISER,
`and DAVID COTTA, Administrative Patent Judges.
`
`KAISER, Administrative Patent Judge.
`
`
`
`
`
`ORDER
`Conduct of the Proceeding
`37 C.F.R. § 42.5
`
`
`
`
`
`
`
`

`

`IPR2021-00406
`Patent 10,716,793 B2
`
`On March 15, 2022, Judges Franklin, Cotta, and Kaiser held a
`conference call with counsel for both parties to discuss Patent Owner’s email
`request for guidance from the Board regarding the scheduling of a deposition
`of one of Petitioner’s reply declarants, Dr. Nicholas Hill. This order
`memorializes the oral orders we issued during the conference call.
`
`
`BACKGROUND
`Petitioner filed its Reply in this proceeding on February 10, 2022.
`Previously, the parties agreed to extend the due date for Patent Owner’s Sur-
`Reply to March 16, 2022, a date Petitioner is unwilling to agree to extend
`further. Along with its Reply, Petitioner filed several declarations of
`witnesses, including one by Dr. Nicholas Hill. See Ex. 1106.
`On or about March 1, 2022, Patent Owner requested that Petitioner
`provide dates when its reply declarants would be available for deposition.
`The parties were able to agree on deposition dates for other witnesses, but
`Petitioner could not provide a date for Dr. Hill’s deposition before the
`March 16 due date of Patent Owner’s Sur-Reply. After apparently
`protracted negotiations, the parties approached us to resolve the dispute.
`Patent Owner argues that it is entitled to take Dr. Hill’s deposition and
`that its Sur-Reply should not be due until after it has had an opportunity to
`take the deposition. Further, Patent Owner argues that, in an attempt to
`make it possible for the deposition to go forward, it offered to reduce the
`length of the deposition to two and a half hours and to take the deposition on
`a weekend or evening, if necessary. Petitioner argues that, due to his clinical
`responsibilities and participation in other litigation, Dr. Hill is unavailable,
`even for a shortened deposition, at any time prior to April 14, 2022. Further,
`
`2
`
`

`

`IPR2021-00406
`Patent 10,716,793 B2
`Petitioner argues that Patent Owner waived its right to the deposition by
`failing to comply with the notice requirement of Rule 42.53(d)(4).
`
`
`ANALYSIS
`Routine discovery in this proceeding includes “[c]ross-examination of
`affidavit testimony prepared for the proceeding.” 37 C.F.R.
`§ 42.51(b)(1)(ii). Because Dr. Hill’s testimony was prepared for this
`proceeding, Patent Owner is entitled to cross-examine Dr. Hill on that
`testimony “within such time period as the Board may set.” Id. It is correct,
`as Petitioner notes, that “[t]he party seeking the deposition must file a notice
`of the deposition at least ten business days before a deposition,” and the
`parties agree that Patent Owner did not comply with this requirement.
`37 C.F.R. § 42.53(d)(4). That said, we do not believe that, at least under the
`circumstances prevailing here, denying an authorized deposition altogether
`is an appropriate sanction for this violation. Accordingly, we decline to find
`that Patent Owner has waived its right to depose Dr. Hill.
`At the same time, we are required to follow a schedule for this
`proceeding that permits us to issue a final written decision no more than one
`year after trial was instituted. 35 U.S.C. § 316(a)(11). Delaying the filing of
`Patent Owner’s Sur-Reply until some time after Dr. Hill becomes available
`for deposition on April 14, 2022, would make following this schedule quite
`difficult, so we also will not pursue this course.
`Instead, Patent Owner’s Sur-Reply will remain due on March 16,
`2022, even though Dr. Hill’s deposition cannot be completed by then. As
`Patent Owner proposed during the conference call, Patent Owner will be
`permitted to take Dr. Hill’s deposition on any date to which the parties can
`agree that falls on or before April 15, 2022. If the parties do not agree to an
`
`3
`
`

`

`IPR2021-00406
`Patent 10,716,793 B2
`earlier date, Petitioner shall make Dr. Hill available for deposition on
`April 15, 2022. The deposition will be limited to two and one-half hours on
`the record. Finally, following Dr. Hill’s deposition, both parties will have an
`opportunity to file two-page observations on cross-examination. These
`observations will be due no later than two business days after the conclusion
`of the deposition.
`
`For the foregoing reasons, it is
`ORDERED that Patent Owner’s Sur-Reply shall be filed no later than
`March 16, 2022;
`FURTHER ORDERED that Petitioner shall produce Dr. Nicholas Hill
`for a deposition, limited to two and one-half hours on the record, no later
`than April 15, 2022;
`FURTHER ORDERED that the parties may agree to a date earlier
`than April 15, 2022, but not to any later date, for Dr. Hill’s deposition; and
`FURTHER ORDERED that both parties are authorized to file
`observations on the cross-examination of Dr. Hill, with each set of
`observations not to exceed two pages, and with both sets of observations due
`no later than two business days after the conclusion of Dr. Hill’s deposition.
`
`
`
`4
`
`

`

`IPR2021-00406
`Patent 10,716,793 B2
`For PETITIONER:
`
`Ivor R. Elrifi
`Erik B. Milch
`Deepa Kannappan
`Sanya Sukduang
`Jonathan R. Davies
`Lauren Krickl
`Douglas Cheek
`COOLEY LLP
`ielrifi@cooley.com
`emilch@cooley.com
`dkannappan@cooley.com
`ssukduang@cooley.com
`jdavies@cooley.com
`lkrickl@cooley.com
`dcheek@cooley.com
`
`For PATENT OWNER:
`
`Stephen B. Maebius
`Jason N. Mock
`FOLEY & LARDNER LLP
`smaebius@foley.com
`jmock@foley.com
`
`Shaun R. Snader
`UNITED THERAPEUTICS CORP.
`ssnader@unither.com
`
`Douglas H. Carsten
`Mandy H. Kim
`MCDERMOTT WILL & EMERY LLP
`dcarsten@mwe.com
`mhkim@mwe.com
`
`
`
`5
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket